![Heather Turner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Heather D.
Turner is Chief Executive Officer & Director at LB Pharmaceuticals, Inc. since 2024.
Ms. Turner is Chairman at Avalyn Pharma, Inc. since 2024.
Ms. Turner is a Member of The State Bar of California.
Former positions include President, Chief Executive Officer & Director at Carmot Therapeutics, Inc.; Independent Director at Terns Pharmaceuticals, Inc. from 2024 to 2026; Senior Vice President & General Counsel at Sangamo Therapeutics, Inc. from 2018 to 2019; Associate General Counsel at Conor Medsystems LLC from 2005 to 2007; Secretary, Senior Vice President & General Counsel at Orexigen Therapeutics, Inc. from 2012 to 2015; Associate at Cooley LLP from 1999 to 2005; Secretary, Executive VP & General Counsel at Atara Biotherapeutics, Inc. from 2015 to 2018; and Secretary & Chief General Counsel at Lyell Immunopharma, Inc. from 2019 to 2023.
Education includes undergraduate studies at the University of California, Santa Barbara and graduate studies at UCLA School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LB PHARMACEUTICALS INC | Director Ejecutivo | 19/11/2024 |
| AVALYN PHARMA INC. | Presidente | 01/10/2024 |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 05/05/2026 |
| LYELL IMMUNOPHARMA, INC. | Consejero General | 05/07/2023 |
| SANGAMO THERAPEUTICS, INC. | Consejero General | 15/03/2019 |
| ATARA BIOTHERAPEUTICS, INC. | Consejero General | 01/02/2018 |
| OREXIGEN THERAPEUTICS, INC. | Consejero General | 25/06/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Develops vascular drug delivery technologies | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Commercial Services |
UCLA School of Law
 UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
